Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 567-572

  Zage, Peter E ^a,d   Reitman, Aaron J ^a   Seshadri, Roopa ^a   Weinstein, Joanna L ^a   Mets, Marilyn B ^a   Zeid, Janice Lasky ^a   Greenwald, Mark J ^b   Strauss, Lewis C ^c   Goldman, Stewart ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemoreduction; Retinoblastoma

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; ETOPOSIDE; TOPOTECAN; VINCRISTINE;

ARTICLE; BACTEREMIA; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FEVER; FUNGEMIA; HEARING LOSS; HUMAN; HYPERTHERMIC THERAPY; INFANT; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RECURRENCE RISK; RETINOBLASTOMA; VISION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLINDNESS; CARBOPLATIN; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRYOTHERAPY; DISEASE PROGRESSION; ETOPOSIDE; EYE ENUCLEATION; HUMANS; HYPERTHERMIA, INDUCED; INFANT; INFANT, NEWBORN; LASER THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; PROSPECTIVE STUDIES; RETINAL NEOPLASMS; RETINOBLASTOMA; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 38549121272     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21301     Document Type: Article

References (29)

1. Hurwitz RL, Shields CL, Shields JA, et al. Retinoblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th ed Philadelphia: Lippincott Williams & Wilkins; 2002. pp 825-846.
2. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004;24:828-848.
3. Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol Clin North Am 2005;18:65-73.
4. Shields CL, Meadows AT, Leahey AM, et al. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina 2004a;24:849-862.
5. Schouten van Meeteren AYN, Moll AC, Imhof SM, et al. Chemotherapy for retinoblastoma: An expanding area of clinical research. Med Pediatr Oncol 2002;38:428-438.
6. Yanagisawa T. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma. Int J Clin Oncol 2004;9:13-24.
7. Chan HSL, Gallie BL, Munier FL, et al. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am 2005;18:55-63.
8. Greenwald MJ, Strauss LC. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 1996;103:1989-1997.
9. Murphree AL. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005;18:41-53.
10. Schiavetti A, Hadjistilianou T, Clerico A, et al. Conservative therapy in intraocular retinoblastoma: Response/recurrence rate. J Pediatr Hematol Oncol 2005;27:3-6.
11. Gunduz K, Gunalp I, Yalcindag N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 2004;111:1917-1924.
12. Friedman DL, Himelstein BP, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-17.
13. Beck MN, Balmer A, Dessing C, et al. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol 2000;18:2881-2887.
14. Brichard B, De Bruycker JJ, De Potter P, et al. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 2002;38:411-415.
15. Kim JH, Yu YS, Khwarg SI, et al. Clinical result of prolonged primary chemotherapy in retinoblastoma patients. Korean J Ophthalmol 2003;17:35-43.
16. Benz MS, Scott IU, Murray TG, et al. Complications of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol 2000;118:577-578.
17. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003;21:2019-2025.
18. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-464.
19. Wilson MW, Rodriguez-Galindo C, Haik BG, et al. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology 2001;108:2106-2115.
20. Hadjistilianou T, Mastrangelo D, De Francesco S, et al. Conservative treatment in unilateral retinoblastoma: A preliminary report. Med Pediatr Oncol 2002;38:439-441.
21. Chantada GL, Fandino AC, Raslawski EC, et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer 2005;44:455-460.
22. Gombos DS, Hungerford J, Abramson DH, et al. Secondary acute myelogenous leukemia in patients with retinoblastoma. Ophthalmology 2007;114:1378-1383.
23. Haupt R, Fears TR, Heise A, et al. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' Cell Histiocytosis in Italian and Austrian-German populations. Int J Cancer 1997;71:9-13.
24. Leone G, Voso MT, Sica S, et al. Therapy related leukemias: Susceptibility, prevention, and treatment. Leuk Lymph 2001;41:255-276.
25. Ogami A, Morimoto A, Hibi S, et al. Secondary acute promyelocytic leukemia following chemotherapy for non-hodgkin's lymphoma in a child. J Pediatr Hematol Oncol 2004;6:427-430.
26. Anderson MK, Johansson B, Larsen SO, et al. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica 1998;83:483-488.
27. Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with Epipodophyllotoxins. J Clin Oncol 1999;17:569-577.
28. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-664.
29. Levy C, Doz F, Quintana E, et al. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: Preliminary results. Br J Ophthalmol 1998;82:1154-1158.